WHO forecasts 81% cancer jump in poorer countries over lacking investments

The Geneva-based World Health Organization (WHO) said in a report that these countries had focused their limited resources on combating infectious diseases and improving maternal and child health

Why aren't cancer drugs better? The targets might be wrong
AFP | PTI Geneva
2 min read Last Updated : Feb 04 2020 | 7:12 AM IST

The UN health agency on Tuesday warned cancer cases would rise by 81 percent in low- and middle-income countries by 2040 because of a lack of investment in prevention and care.

The Geneva-based World Health Organization (WHO) said in a report that these countries had focused their limited resources on combating infectious diseases and improving maternal and child health instead of fighting cancer. It said they often had the highest cancer mortality too.

"This is a wake-up call to all of us to tackle the unacceptable inequalities between cancer services in rich and poor countries," Ren Minghui, a WHO Assistant Director General, said in the report.

"If people have access to primary care and referral systems then cancer can be detected early, treated effectively and cured. Cancer should not be a death sentence for anyone, anywhere," he said.

The report, timed to coincide with World Cancer Day, said an investment of $25 billion (23 billion euros) over the next decade could save seven million lives from cancer.

"Controlling cancer does not have to be expensive," Andre Ilbawi, of the WHO's department for management of non-communicable diseases, told journalists.

The annual report found that overall cancer cases in the world would rise by 60 percent by 2040 and said tobacco use was responsible for 25 percent of cancer deaths.

Elisabete Weiderpass, director of the International Agency for Research on Cancer, which works with the WHO, said better cancer treatment in high-income countries had resulted in a 20-percent drop in mortality between 2000 and 2015.

But in poorer countries, the reduction was just five percent.

"We need to see everyone benefiting equally," she said.

While cancer had long been considered a disease of wealthy countries, this was no longer the case, the report said. It pointed out that one in five people worldwide would face a cancer diagnosis in their lifetime.

"It's a global burden," Ren said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :World Health OrganisationWHOcancercancer drugs

First Published: Feb 04 2020 | 4:55 AM IST

Next Story